In this powerful episode of IMA TALKS, host Khushi Gandhi sits down with Dr. Priyabrata Pattnaik, CEO of Ami Polymer and a veteran in infectious disease research, bioprocessing, and vaccine development. From surviving cerebral malaria and a life-changing coma at 19 in a remote tribal area, to leading critical components manufacturing for global biologics, Dr. Pattnaik shares a deeply personal and insightful journey at the intersection of science, resilience, and real-world impact. Key Highlights: • His near-death experience with malaria and why access to healthcare — especially the "last mile" — remains one of the biggest challenges in global health • The evolution of vaccine platforms (from traditional inactivated vaccines to mRNA), manufacturing scale-up hurdles, purification challenges, and what truly drives vaccine costs • Lessons from Ebola, COVID-19, and Disease X: Why in-country capacity, supply chain resilience, and balancing emergency response with routine immunization are critical for future preparedness • Leadership wisdom for scientists and young professionals: The power of curiosity, asking "why," embracing gray spaces in decision-making, and staying true to your North Star Dr. Pattnaik also discusses Atmanirbhar Bharat’s role in vaccine self-reliance, the promise and realities of new technologies, and practical advice for the next generation entering life sciences. Whether you're a healthcare professional, student, policymaker, or simply curious about how science turns into lifesaving impact, this conversation offers profound takeaways on innovation, equity, and preparedness. 🎧 Listen now and discover what it really takes to build resilient health systems. If you enjoyed this episode, like, subscribe to IMA Talks for more conversations where science meets story, and share it with someone passionate about healthcare and innovation. Turn on notifications so you never miss an episode! 00:00 Coma Survivor Story 00:25 Ebola Preparedness Reality 00:50 Curiosity And Risk 01:39 Show Intro And Guest 03:11 Near Death Malaria Lessons 05:16 How Vaccines Work 07:20 Why Malaria Vaccine Hard 09:40 Vaccine Platforms Evolution 12:00 mRNA Breakthrough Limits 13:40 Scaling Lab To Factory 15:59 Vaccine Supply Chain Map 19:16 Purification Cost Challenge 21:16 Quality By Design GMP 23:21 What Drives Vaccine Cost 24:44 Indigenous Manufacturing Push 28:45 Innovation Needs Buyers 30:11 Pandemic Supply Chain Gaps 33:08 Outbreak Response Together 34:19 Ebola Systems Not Just Vaccine 37:29 Cold Chain Never Break 38:34 Myth And Supply Chain 38:51 Rapid Fire Vaccine Takes 39:56 Purpose And The Five Whys 42:15 Politics And Vaccine Access 43:47 Disease X And Unknown Threats 44:49 Zero Dose Immunization Gap 46:50 Innovation Versus Last Mile 49:11 India Asia Manufacturing Rise 50:52 Tech Transfer Trust Explained 54:06 Future Of Biomanufacturing 55:53 Leading In Gray Space 01:03:17 Gen Z Purpose Discipline 01:05:32 Read Rooms Fix Systems 01:08:49 Ambi Polymer Healthcare Vision 01:11:03 Final Advice And Farewell #Vaccines #HealthcareInnovation #PandemicPreparedness #Biologics #imatalks Visit our social media pages: LinkedIn: / published Instagram: / amipolymer
